NCT02521545View on ClinicalTrials.gov

Single-Dose Study of a New Formulation of BIIB061

PHASE1CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions

Multiple Sclerosis

Interventions

DRUG

BIIB061

Capsule

Trial Locations (1)

53704

Research Site, Madison

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Biogen

INDUSTRY

NCT02521545 - Single-Dose Study of a New Formulation of BIIB061 | Biotech Hunter | Biotech Hunter